The World Health Organization (WHO) is a specialized agency of the United Nations that is responsible for promoting and coordinating international health activities. One of the key areas of focus for WHO is to ensure that pharmaceutical products are of high quality and safe for use.To this end, WHO has developed a set of guidelines for Good Manufacturing Practice (GMP) that are widely recognized as the global standard for pharmaceutical manufacturing. These guidelines outline the minimum requirements that pharmaceutical manufacturers must meet in order to ensure that their products are consistently produced and controlled in accordance with their intended quality and safety standards.
WHO-GMP covers all aspects of the manufacturing process, including the facilities, equipment, personnel, documentation, and procedures involved in the production and testing of pharmaceutical products. The guidelines are designed to ensure that each stage of the process is properly documented, controlled, and monitored to minimize the risk of contamination or errors.WHO-GMP guidelines are important because they provide a framework for ensuring that pharmaceutical products are of high quality and safe for use. Compliance with WHO-GMP is often required by regulatory authorities before a pharmaceutical product can be approved for sale, and failure to meet WHO-GMP standards can result in fines, product recalls, or other legal consequences.
In addition to setting the standard for pharmaceutical manufacturing, WHO also provides technical assistance and training to help manufacturers meet GMP guidelines. This includes conducting inspections of manufacturing facilities to ensure compliance with GMP standards, as well as providing guidance on best practices and quality control.WHO-GMP is an essential tool for ensuring that pharmaceutical products are of high quality and safe for use. By following these guidelines, pharmaceutical manufacturers can help to ensure that their products meet regulatory requirements and are trusted by healthcare professionals and consumers around the world.
New Drugs, SND, FDC, API, Bulk Drugs, Test Licenses, BE NOC, etc. for importers, manufacturers and traders
Regulatory support for FSSAI. Import assistance, Licensing and registration, FSSAI compliance, Product Approval
Medical device registration, Import license, Clarification from CDSCO, Performance evaluation
Registration of biologicals, Import license, Test license, Export NOC, Regulatory support for CLAA
Registration of biologicals, Import license, Test license, Export NOC, Regulatory support for CLAA
Registration of biologicals, Import license, Test license, Export NOC, Regulatory support for CLAA
R.P/C.P
The medicines need to be handled with by a specialist, and for that matter, there is a requirement of a qualified pharmacist in case of retail drug license and in case of wholesale a graduate with 1 years experience or undergraduate having four years experience is must or any Diploma or Bachelor degree in Pharmacy.
Area For Drug Licence
For opening a pharmacy business, the carpet area of the pharmacy must be a minimum of 10 square meters, and in case the application is for both retail and wholesale pharmacy the minimum area prescribed in 15 square meters. The premises must be commercial and adequately ventilated.
I had been struggling to navigate the complex and ever-changing landscape of Indian regulatory services for years, until I found a reliable partner in Barrolex Consultants. Their team of experts not only helped me understand the intricacies of various regulations, but also provided invaluable.
I recently purchased a Miscellaneous product from this company and was blown away by the quality and attention to detail. The product exceeded my expectations and has been an essential part of my daily routine ever since.
cannot recommend Global Regulatory Services enough. Their team of experts provided us with invaluable guidance and support as we navigated the complex and ever-changing regulatory landscape. Thanks to their expertise,
Proactively revolutionize granular customer service after pandemic internal or "organic" sources. Distinctively impact proactive human capital rather than client-centered benefits.
Professionally impact distributed data via value-added experiences. Proacti incentivize 24/365 applications whereas turnkey total linkage. whiteboard multifunctional channels with interoperable value.
Professionally impact distributed data via value-added experiences. Proacti incentivize 24/365 applications whereas turnkey total linkage. whiteboard multifunctional channels with interoperable value.
Professionally impact distributed data via value-added experiences. Proacti incentivize 24/365 applications whereas turnkey total linkage. whiteboard multifunctional channels with interoperable value.
Professionally impact distributed data via value-added experiences. Proacti incentivize 24/365 applications whereas turnkey total linkage. whiteboard multifunctional channels with interoperable value.
Professionally impact distributed data via value-added experiences. Proacti incentivize 24/365 applications whereas turnkey total linkage. whiteboard multifunctional channels with interoperable value.
Professionally impact distributed data via value-added experiences. Proacti incentivize 24/365 applications whereas turnkey total linkage. whiteboard multifunctional channels with interoperable value.
